1996年

Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type I infected cell line, MT-2.
Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K.
J. Virol., 70(10):7219-23 (1996)

Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes.
Kato N, Ikeda M, Mizutani T, Sugiyama K, Noguchi M, Hirohashi S, Shimotohno K.
Jpn. J. Cancer Res., 87(8):787-92 (1996)

Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
Kondo M, Tanaka K, Ikeda M, Arata S, Saito S, Sakaguchi T, Morimoto M, Fujii T, Mitsui K, Okazaki H, Hoshino M, Sekihara H.
J Gastroenterol Hepatol., 11(3):236-40 (1996)

Efficacy of ursodeoxycholic acid in combination with interferon-alpha in treating chronic hepatitis C: results of a long-term follow-up trial.
Tanaka K, Kondo M, Sakaguchi T, Saito S, Arata S, Ikeda M, Kitamura T, Morimoto M, Sekihara H.
J Gastroenterol Hepatol., 11(12):1155-60 (1996)

Long-term human T-cell culture system supporting hepatitis C virus replication.
Mizutani T, Kato N, Ikeda M, Sugiyama K, Shimotohno K.
Biochem Biophys Res Commun., 227(3):822-6 (1996)

Promoter selectivity of Escherichia coli RNA polymerase E sigma 70 and E sigma 38 holoenzymes. Effect of DNA supercoiling.
Kusano S, Ding Q, Fujita N, Ishihama A.
J Biol Chem., 271(4):1998-2004 (1996)